HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Gisbert Weckbecker Selected Research
Gisbert Weckbecker Research Topics
Disease
4
Multiple Sclerosis
01/2022 - 01/2019
4
Neoplasms (Cancer)
01/2021 - 02/2002
3
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 01/2019
3
Adenoma (Adenomas)
04/2005 - 04/2004
2
Infections
01/2022 - 01/2021
2
Demyelinating Diseases (Demyelinating Disease)
01/2021 - 01/2019
2
Inflammation (Inflammations)
01/2019 - 04/2015
2
Pituitary ACTH Hypersecretion
01/2014 - 04/2005
2
Pituitary Neoplasms (Pituitary Adenoma)
06/2004 - 04/2004
1
Hypersensitivity (Allergy)
01/2022
1
Tertiary Lymphoid Structures
01/2022
1
Atrophy
01/2021
1
Autoimmune Diseases (Autoimmune Disease)
01/2021
1
Coinfection
01/2021
1
Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2021
1
Pneumocystis Infections
01/2021
1
Rheumatoid Arthritis
01/2020
1
Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1
Neuroinflammatory Diseases
12/2019
1
Crohn Disease (Crohn's Disease)
06/2013
1
Colitis
06/2013
1
Psoriasis (Pustulosis Palmaris et Plantaris)
09/2011
1
Carcinogenesis
07/2008
1
ACTH-Secreting Pituitary Adenoma
04/2005
1
Acromegaly
06/2004
1
Prolactinoma (Prolactinomas)
04/2004
1
Growth Hormone-Secreting Pituitary Adenoma
04/2004
1
Body Weight (Weight, Body)
08/2002
1
Seizures (Absence Seizure)
02/2002
1
Pain (Aches)
02/2002
1
Vascular Remodeling
02/2002
Drug/Important Bio-Agent (IBA)
4
pasireotide
IBA
01/2014 - 04/2004
4
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
04/2005 - 08/2002
3
Messenger RNA (mRNA)
IBA
04/2005 - 08/2002
3
Octreotide (Sandostatin)
FDA Link
Generic
06/2004 - 08/2002
2
ofatumumab
FDA Link
01/2022 - 01/2019
2
Myelin-Oligodendrocyte Glycoprotein
IBA
01/2021 - 01/2019
2
Monoclonal Antibodies
IBA
01/2019 - 01/2019
2
Insulin-Like Growth Factor I (IGF-1)
IBA
06/2004 - 08/2002
1
ocrelizumab
IBA
01/2022
1
Vaccines
IBA
01/2022
1
Antigens
IBA
01/2021
1
Immunoglobulins (Immunoglobulin)
IBA
01/2021
1
Interferon-gamma (Interferon, gamma)
IBA
01/2021
1
Interleukins
IBA
01/2021
1
Rituximab (Mabthera)
FDA Link
01/2020
1
Lipopolysaccharides
IBA
12/2019
1
keyhole-limpet hemocyanin (keyhole limpet hemocyanin)
IBA
12/2019
1
Zirconium-89
IBA
01/2019
1
Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein
IBA
04/2015
1
Proteins (Proteins, Gene)
FDA Link
06/2013
1
Staphylococcal Protein A (Protein A)
IBA
06/2013
1
sotrastaurin
IBA
09/2011
1
Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)
IBA
07/2008
1
Ligands
IBA
04/2005
1
Adrenocorticotropic Hormone (ACTH)
FDA Link
04/2005
1
somatostatin receptor 5
IBA
04/2005
1
somatostatin receptor 2
IBA
06/2004
1
Somatostatin Receptors (Somatostatin Receptor)
IBA
06/2004
1
Prolactin
IBA
04/2004
1
Growth Hormone (Somatotropin)
IBA
04/2004
1
Hormones (Hormone)
IBA
04/2004
1
peptide 32
IBA
08/2002
1
Glucagon (Glukagon)
FDA Link
02/2002
1
Insulin (Novolin)
FDA Link
02/2002
1
Glutamic Acid (Glutamate)
FDA Link
02/2002
Therapy/Procedure
4
Therapeutics
01/2022 - 01/2019
1
Treatment Delay
01/2021
1
Intravenous Administration
01/2019